Caprock Group LLC Makes New Investment in Colgate-Palmolive Company $CL

Caprock Group LLC purchased a new stake in Colgate-Palmolive Company (NYSE:CL) during the third quarter, according to its most recent 13F filing with the SEC. The firm purchased 29,929 shares of the company’s stock, valued at approximately $2,516,000.

Other large investors have also recently modified their holdings of the company. Brighton Jones LLC increased its position in shares of Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares in the last quarter. Woodline Partners LP increased its position in Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after buying an additional 20,062 shares in the last quarter. MGO One Seven LLC raised its stake in Colgate-Palmolive by 107.2% in the second quarter. MGO One Seven LLC now owns 14,351 shares of the company’s stock valued at $1,304,000 after buying an additional 7,424 shares during the last quarter. Sequoia Financial Advisors LLC boosted its holdings in Colgate-Palmolive by 18.6% in the second quarter. Sequoia Financial Advisors LLC now owns 30,273 shares of the company’s stock worth $2,752,000 after acquiring an additional 4,738 shares in the last quarter. Finally, RFG Advisory LLC grew its stake in shares of Colgate-Palmolive by 1.4% during the second quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock worth $839,000 after acquiring an additional 123 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE CL opened at $96.17 on Friday. The firm has a market capitalization of $77.52 billion, a P/E ratio of 36.70, a PEG ratio of 4.30 and a beta of 0.29. The stock has a 50-day simple moving average of $83.43 and a two-hundred day simple moving average of $81.83. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same period last year, the company earned $0.91 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 5.8% compared to the same quarter last year. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Wednesday, January 21st. Colgate-Palmolive’s payout ratio is currently 79.39%.

Analysts Set New Price Targets

CL has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. Barclays lifted their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 3rd. The Goldman Sachs Group reissued a “buy” rating and set a $94.00 price objective on shares of Colgate-Palmolive in a report on Saturday, January 31st. UBS Group raised their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Finally, Evercore lifted their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research report on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.47.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the sale, the chief financial officer owned 55,310 shares in the company, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the transaction, the insider owned 17,645 shares of the company’s stock, valued at approximately $1,663,041.25. This trade represents a 54.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 134,683 shares of company stock valued at $12,708,193. Corporate insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.